首页|艾司氯胺酮复合羟考酮在剖宫产术后镇痛中的相互作用和配伍方案优化

艾司氯胺酮复合羟考酮在剖宫产术后镇痛中的相互作用和配伍方案优化

扫码查看
目的 探讨艾司氯胺酮复合羟考酮在剖宫产术后镇痛中的相互作用和配伍方案优化。方法 选择2021年4月至2022年10月于浙江省中医院接受剖宫产术的138例产妇为研究对象,选择艾司氯胺酮与羟考酮靶控输注起始配伍浓度,观察患者麻醉后的视觉模拟(VAS)评分≤3分的疼痛感消失时间(TLOP),依据手术过程中脑电双频谱指数(BIS)、平均动脉压(MAP)和心率(HR)调整艾司氯胺酮与羟考酮的靶控输注浓度,维持BIS 42~65、MAP ≥ 60 mmHg、HR>50次/min。记录艾司氯胺酮与羟考酮输注后至VAS评分≥3分的疼痛感恢复时间(TROP)。采用点斜法计算各组药物在半数患者入睡BIS值(BIS50)时的半数有效量(ED50)。应用响应曲面模型分析艾司氯胺酮与羟考酮在剖宫产术后镇痛中的药效学相互作用,并计算最佳配伍浓度范围。结果 在BIS值为50时,艾司氯胺酮复合羟考酮ED50偏离相加线无统计学意义(P>0。05)。复合药物效应(复合点SP)落在相加线左侧,提示在镇痛效应上两药为协同作用。响应曲面模型显示艾司氯胺酮与羟考酮在行剖宫产术的患者术后镇痛过程中的体动反应和循环反应上具有显著协同作用,其最佳配伍浓度范围为:靶控输注羟考酮浓度为2 mg/mL时,使用艾司氯胺酮0。38~0。80 mg/kg;靶控输注羟考酮浓度为3 mg/mL时,使用艾司氯胺酮0。30~0。70 mg/kg;靶控输注羟考酮浓度为4 mg/mL时,使用艾司氯胺酮0。23~0。46 mg/kg;靶控输注羟考酮浓度为5 mg/mL时,使用艾司氯胺酮0。18~0。37 mg/kg;靶控输注羟考酮浓度为6 mg/mL时,使用艾司氯胺酮0。20 mg/kg。结论 艾司氯胺酮与羟考酮靶控输注在剖宫产术后镇痛中呈协同作用,不同的药效反应相结合创建出的艾司氯胺酮与羟考酮最佳配伍剂量范围,在最佳配伍浓度范围内可以为患者提供良好的镇痛效果,并且具有较少的不良反应。
Optimization of interaction and compatibility of esketamine combined with oxycodone in postoperative analgesia after cesarean section
Objective To explore the interaction and compatibility optimization of esketamine combined with oxycodone in postoperative analgesia after cesarean section.Methods A total of 138 postpartum women who received cesarean section in Zhejiang Provincial Hospital of Chinese Medicine from April 2021 to October 2022 were selected as the study subjects.The initial compatibility concentration of target-controll infusion of esketamine and oxycodone was selected,and the pain disappearance time(TLOP)of patients after anesthesia,who visual analogue scale(VAS)scores<3 was observed.The target-controlled infusion concentrations of esketamine and oxycodone were adjusted according to bispectral index(BIS),mean arterial pressure(MAP)and heart rate(HR)during operation,and BIS 42-65,MAP>60 mmHg and HR>50 times/min were maintained.The pain recovery time(TROP)from esketamine and oxycodone infusion to VAS score>3 was recorded.The median effective dose(ED50)of each group of drugs at BIS50 was calculated by point-slope method.The pharmacodynamic interaction of esketamine and oxycodone in postoperative analgesia after cesarean section was analyzed by response surface model,and the optimal compatible concentration range was calculated.Results When the BIS value was 50,ED50 of esketamine combined with oxycodone deviated from the addition line without statistical significance(P>0.05).The compound drug effect(compound point SP)fell to the left of the addition line,indicating that the analgesic effect of the two drugs was synergistic.The response surface model showed that esketamine and oxycodone had a significant synergistic effect on the body motor response and circulation response during postoperative analgesia in patients undergoing cesarean section.The optimal compatible concentration range was as follows:when the concentration of oxycodone was 2 mg/mL,0.38-0.80 mg/kg esketamine was used;when the concentration of oxycodone was 3 mg/mL,0.30-0.70 mg/kg esketamine was used;when the concentration of oxycodone was 4 mg/mL,0.23-0.46 mg/kg esketamine was used;when the concentration of oxycodone was 5 mg/mL,0.18-0.37 mg/kg esketamine was used;when the concentration of oxycodone was 6 mg/mL,0.20 mg/kg esketamine was used.Conclusion The target-controlled infusion of esketamine and oxycodone target controlled infusion has a synergistic effect in postoperative analgesia after cesarean section.The combination of different pharmacodynamic responses creates the optimal dosage range of esketamine and oxycodone,which can provide patients with good analgesia effect and fewer adverse reactions within the optimal concentration range.

EsketamineOxycodoneResponse surface modelCaesarean sectionInteractionOptimal compatible dose

陈禹孜、李莉、葛燕露

展开 >

浙江省中医院麻醉科(杭州 310003)

浙江省中医院妇产科(杭州 310003)

艾司氯胺酮 羟考酮 响应曲面模型 剖宫产 相互作用 最佳配伍剂量

2024

中国药师
国家药品监督管理局高级研修学院,武汉医药(集团)股份有限公司

中国药师

CSTPCD
影响因子:0.944
ISSN:1008-049X
年,卷(期):2024.27(4)
  • 26